Ms Sally S Jones-evans, MSW ACSW LMFT | |
3010 E State Blvd, Fort Wayne, IN 46805 | |
(260) 471-2300 | |
(260) 471-2778 |
Full Name | Ms Sally S Jones-evans |
---|---|
Gender | Female |
Speciality | Social Worker |
Location | 3010 E State Blvd, Fort Wayne, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932216314 | NPI | - | NPPES |
000000309372 | Other | ANTHEM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 35000877A (Indiana) | Primary |
104100000X | Social Worker | (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Sally S Jones-evans, MSW ACSW LMFT 3010 E State Blvd, Center For Neurobehavioral Services, Fort Wayne, IN 46805 Ph: (260) 471-2300 | Ms Sally S Jones-evans, MSW ACSW LMFT 3010 E State Blvd, Fort Wayne, IN 46805 Ph: (260) 471-2300 |
News Archive
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
News outlets continue to examine how Solvadi - usually an expensive cure for hepatitis-C - might affect budgets.
"House Democratic leaders are moving forward with Plan B for passing health care reform by introducing a stand-alone measure to strip the antitrust exemption for health insurance companies — a popular piece of their stalled health care reform package," Roll Call reports. "Freshmen Reps. Tom Perriello (D-Va.) and Betsy Markey (D-Colo.) will file legislation on Friday aimed at barring the insurance industry from fixing prices and setting their own markets without being investigated.
Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.
As states and the federal government begin creating insurance exchanges under the health law, researchers highlight several lessons from Switzerland and the Netherlands.
› Verified 3 days ago